SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
BIOMARIN PHARMACEUTICALS
(NQNM:BMRN Last Sale: 90.36 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (BMRN : $90.36)
$16,333,542 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today
105 Digital Drive Research Report Earnings Snapshot - Last 10/23/18
Novato, CA 94949 Fact Sheet
Phone: (415) 506-6700 Financial Statements
Fax: (415) 382-7427 Peer Comparison
Annual Reports

Jean-Jacques Bienaimé, CEO, Jeffrey H. Cooper, CFO
Formed in a Spin-off by Glyko Biomedical Ltd. (TSE:GBL/OTCBB:GLYK/Berlin: GLY), which retains 33.3%. Specializes in the discovery, development and commercialization of therapeutic products using carbohydrate-active enzymes. IPO at $13 July 22, 1999. Raised $58.5 million, selling 4.5 million shares, 13% of the outstanding. Lead Manager: Piper Jaffray.
Historical Charts    Technical Analysis
No Historical Data available for BMRN

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common BMRN $90.36 $90.36 0 .0 $86.77 $90.4 1,458,635 $86.77 $90.4 180,760,753
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex